1st Circ. Rules Against Pfizer In 3 Neurontin RICO Suits
The First Circuit on Wednesday dealt Pfizer Inc. three major defeats over Neurontin litigation, ruling that the company's fraudulent marketing of the epilepsy drug directly caused Kaiser Foundation Health Plan Inc.,...To view the full article, register now.
Already a subscriber? Click here to view full article